Skip to main content

Exposure to Low-Dose Ionizing Radiation Linked to Solid Cancer Mortality

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

MONDAY, Aug. 21, 2023 -- Protracted exposure to low-dose ionizing radiation is associated with an increased risk for solid cancer mortality, according to a study published online Aug. 16 in The BMJ.

David B. Richardson, Ph.D., from the University of California in Irvine, and colleagues examined the effect of protracted low-dose exposure to ionizing radiation on the risk for cancer in a multinational cohort study involving workers in the nuclear industry in France, the United Kingdom, and the United States. Participants included 309,932 workers with individual monitoring data for external exposure to ionizing radiation, with follow-up of 10.7 million person-years.

The researchers identified 103,553 deaths, including 28,089 due to solid cancers. There was a 52 percent increase in the estimated rate of mortality due to solid cancer with cumulative dose per Gy, which lagged by 10 years. The estimate of association was approximately doubled on restriction of the analysis to the low cumulative dose range (0 to 100 mGy) and with restricting the analysis to workers hired in more recent years, when estimates of occupational external radiation were more accurate. The estimated magnitude of the association was modestly affected by exclusion of deaths from lung cancer and pleural cancer, indirectly indicating that the association was not substantially confounded by smoking or asbestos exposure.

"The study provides evidence in support of a linear association between protracted low-dose external exposure to ionizing radiation and solid cancer mortality," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted August 2023

Read this next

Second Tumors Are Rare After Chimeric Antigen Receptor T-Cell Therapy

FRIDAY, June 14, 2024 -- Second tumors are rarely seen after chimeric antigen receptor (CAR) T-cell therapy, according to a study published in the June 13 issue of the New England...

Health Care Spending Growth Projected to Outpace GDP to 2032

THURSDAY, June 13, 2024 -- Health care spending growth is projected to outpace that of the gross domestic product (GDP) during the coming decade, according to a study published...

Generation X Experiencing Larger Per-Capita Increases in Cancer Incidence

WEDNESDAY, June 12, 2024 -- Generation X is experiencing larger per-capita increases in the incidence of cancers than Baby Boomers, according to a study published online June 10...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.